
HRTX Valuation
Heron Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
HRTX Relative Valuation
HRTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HRTX is overvalued; if below, it's undervalued.
Historical Valuation
Heron Therapeutics Inc (HRTX) is now in the Fair zone, suggesting that its current forward PS ratio of 1.77 is considered Fairly compared with the five-year average of -4.62. The fair price of Heron Therapeutics Inc (HRTX) is between 0.89 to 9.05 according to relative valuation methord.
Relative Value
Fair Zone
0.89-9.05
Current Price:1.91
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-10.18
P/B
Median3y
-5.44
Median5y
-0.05
-7.93
FCF Yield
Median3y
-32.73
Median5y
-28.55
Competitors Valuation Multiple
The average P/S ratio for HRTX's competitors is 1.92, providing a benchmark for relative valuation. Heron Therapeutics Inc Corp (HRTX) exhibits a P/S ratio of 1.83, which is -4.80% above the industry average. Given its robust revenue growth of 12.21%, this premium appears unsustainable.
People Also Watch

HLXB
Helix Acquisition Corp II
10.695
USD
-0.33%

CPSS
Consumer Portfolio Services Inc
9.100
USD
-0.22%

LUNG
Pulmonx Corp
3.340
USD
+0.75%

DMAC
DiaMedica Therapeutics Inc
5.050
USD
+3.48%

NGNE
Neurogene Inc
22.720
USD
-0.39%

ZYXI
Zynex Inc
2.580
USD
+1.98%

TZOO
Travelzoo
10.800
USD
-3.05%

AENT
Alliance Entertainment Holding Corp
5.625
USD
-7.71%

EIC
Eagle Point Income Company Inc
12.950
USD
+2.86%

ATAI
ATAI Life Sciences NV
3.570
USD
-4.55%
FAQ

Is Heron Therapeutics Inc (HRTX) currently overvalued or undervalued?
Heron Therapeutics Inc (HRTX) is now in the Fair zone, suggesting that its current forward PS ratio of 1.77 is considered Fairly compared with the five-year average of -4.62. The fair price of Heron Therapeutics Inc (HRTX) is between 0.89 to 9.05 according to relative valuation methord.

What is Heron Therapeutics Inc (HRTX) fair value?

How does HRTX's valuation metrics compare to the industry average?

What is the current P/B ratio for Heron Therapeutics Inc (HRTX) as of Jul 26 2025?

What is the current FCF Yield for Heron Therapeutics Inc (HRTX) as of Jul 26 2025?

What is the current Forward P/E ratio for Heron Therapeutics Inc (HRTX) as of Jul 26 2025?
